The leverage equation has changed
For most of the 2010s and into the early 2020s, private equity returns were built on a three-part formula: buy at a reasonable multiple, apply significant leverage, and sell into a rising market. Each leg of that stool reinforced the others. Low base rates made debt cheap. Expanding multiples meant exits rewarded patience. And abundant credit meant sponsors could optimize capital structures aggressively.
That formula is under strain. The Federal Reserve's rate-hiking cycle pushed base rates to levels not seen since before the global financial crisis, and while markets have priced in eventual cuts, the forward curve no longer offers the near-zero floor that made 2019-era LBO models look conservative in hindsight. The cost of a leveraged loan — the primary instrument for large buyout financing — has risen accordingly.
The practical effect is straightforward: for a given purchase price, the same capital structure now generates less return. Sponsors either accept lower IRRs, reduce the purchase price, or increase the equity check. None of those options is painless.
Sellers haven't fully adjusted
The bid-ask problem is not new to deal markets, but the current version has unusual staying power. Private company sellers — particularly founder-owned businesses and portfolio companies held by earlier-vintage funds — are often benchmarking against transaction multiples from 2020 and 2021, when cheap debt and competitive auction processes pushed valuations to cyclical highs in many sectors.
Public equity markets have already repriced. The S&P 500's forward earnings multiple contracted meaningfully from its 2021 peak, and publicly traded companies in sectors like software and healthcare services saw significant valuation resets. Private markets tend to lag that adjustment, partly because there is no daily mark and partly because sellers have the option to wait.
Waiting has a cost, though. Funds raised in 2018 and 2019 are approaching the end of their typical investment periods. Limited partners expecting distributions are watching holding periods extend. The pressure to transact — on both the buy side and the sell side — will build as time passes, even if it hasn't yet forced widespread price concessions.
Exit assumptions are the harder problem
Buying at the right price matters, but private equity returns are ultimately realized at exit. And the exit environment is complicated in ways that go beyond current multiples.
The IPO market, which provided a meaningful exit route during the 2020-2021 window, has been largely closed to sponsor-backed companies for much of the past two years. Listings that did proceed often priced below initial expectations or traded poorly in the aftermarket, discouraging further supply. A sustained reopening of the IPO window would require both stable equity markets and investor appetite for new issuance — conditions that have been intermittent at best.
Strategic acquirers, the other major exit route, face their own constraints. Corporate buyers dealing with higher financing costs and board-level scrutiny of capital allocation are more selective than they were during the low-rate era. That narrows the buyer universe and reduces competitive tension in sale processes, which tends to compress exit multiples.
Sponsors underwriting new deals today are making assumptions about exit conditions three to seven years out. Those assumptions are necessarily uncertain, but the range of plausible outcomes is wider than it was when rates were anchored near zero and multiple expansion seemed like a reasonable base case.
Where deals are still getting done
Deal activity has slowed, but it has not stopped. The transactions that are closing tend to share certain characteristics.
Add-on acquisitions within existing platforms account for a growing share of sponsor deal volume. These transactions are structurally easier: the acquiring entity already has a credit facility, the integration thesis is narrower, and the strategic rationale is easier to articulate to lenders. For a sponsor trying to deploy capital without taking on full platform risk, bolt-ons offer a path.
Credit-oriented strategies — including direct lending, distressed debt, and structured equity — have attracted capital as traditional buyout activity has slowed. The rise of private credit as an asset class has also changed the financing landscape for mid-market buyouts, with direct lenders often able to move faster and with more flexibility than syndicated loan markets.
Sectors with durable cash flows and limited cyclical exposure — infrastructure-adjacent businesses, essential services, certain healthcare subsectors — continue to attract buyer interest, even at prices that require careful underwriting. Sponsors are willing to pay for predictability when the macro environment is uncertain.
What to watch
The deal market's trajectory depends on a small number of variables that are genuinely difficult to forecast. Credit market conditions — specifically the availability and pricing of leveraged finance — are the most immediate constraint on large-cap buyout activity. A sustained tightening of spreads or a pullback by lenders would further reduce deal flow; an easing would unlock transactions that are currently on hold.
Seller price expectations are the second variable. The longer current conditions persist, the more pressure accumulates on sellers who need liquidity — whether that's a founder approaching retirement, a fund manager facing LP pressure, or a corporate divesting a non-core asset. Price discovery tends to happen at the margin, and a few high-profile transactions at adjusted multiples can shift market expectations faster than gradual negotiation.
Regulatory posture matters as well, particularly for large transactions in concentrated sectors. Antitrust scrutiny has added time and uncertainty to deal processes, and the cost of a failed transaction — in legal fees, management distraction, and reputational terms — has risen. Sponsors are factoring regulatory risk into deal selection in ways that weren't standard practice five years ago.
None of this means the deal market is broken. It means the market is repricing. That process is uncomfortable for participants on both sides of the table, but it is also how markets clear.